Children whose mothers used paracetamol during their pregnancy may have a slightly increased risk of childhood wheeze, according to a meta-analysis published in the April issue of Clinical & Experimental Allergy.
MONDAY, April 11 (HealthDay News) -- Children whose mothers used paracetamol during their pregnancy may have a slightly increased risk of childhood wheeze, according to a meta-analysis published in the April issue of Clinical & Experimental Allergy.
Sally Eyers, M.B.Ch.B., from the Medical Research Institute of New Zealand in Wellington, and colleagues reviewed six studies involving children aged 2.5 to 7 years to assess the association between paracetamol use during pregnancy and subsequent asthma in childhood. Wheeze in the last 12 months was the primary outcome variable. Raw data, unadjusted for confounding factors, were pooled to produce a random effects odds ratio (OR).
The researchers found that there was a slightly increased risk of current wheeze in children whose mothers were exposed to any paracetamol during their pregnancy (pooled random effects OR, 1.21). The studies variably included correlations between the use of paracetamol during all trimesters of pregnancy and persistent asthma, severe asthma, and atopy.
"More research is urgently required to determine the impact of paracetamol during pregnancy on the risk of wheezing in offspring so that appropriate public health recommendations can be made," the authors write.
AbstractFull Text (subscription or payment may be required)
Related Content
Makena Debuts, but at What Cost?Makena Update: FDA Opens Up Competition, KV Pharmaceuticals Improves Access
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Similar delivery times between misoprostol dosages among obese patients reported
May 29th 2024A recent study found that obese patients undergoing induction of labor experienced similar delivery times regardless of whether they received 50 μg or 25 μg of vaginal misoprostol, though multiparous patients showed faster delivery with the higher dosage.
Read More